NCT06540937 2024-08-07
Phase II Clinical Study of Leflunomide in the Treatment of MEN-1 Neuroendocrine Tumor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
National Institutes of Health Clinical Center (CC)
Stanford University
Federico II University